Records 1 - 5
| Association between MDM2 rs 2279744 polymorphism and breast cancer susceptibility: a meta-analysis based on 9,788 cases and 11,195 controls.
Therapeutics and clinical risk management 2014 10 269-77.
Gao Jie, Kang An-Jing, Lin Shuai, Dai Zhi-Jun, Zhang Shu-Qun, Liu Di, Zhao Yang, Yang Peng-Tao, Wang Meng, Wang Xi-Ji
| Individual and combined effects of MDM2 SNP309 and TP53 Arg72Pro on breast cancer risk: an updated meta-analysis.
Molecular biology reports 2012 Sep 39 (9): 9265-74.
Cheng Hongtao, Ma Biao, Jiang Ran, Wang Wei, Guo Hui, Shen Na, Li Dapeng, Zhao Qunzi, Wang Rui, Yi Pengfei, Zhao Yue, Liu Zeming, Huang T
| MDM2 SNP309 polymorphism and breast cancer risk: a meta-analysis.
Molecular biology reports 2012 Apr 39 (4): 3471-7.
Zhao Erjiang, Cui Dan, Yuan Ling, Lu Weiqu
| Differential effects of MDM2 SNP309 polymorphism on breast cancer risk along with race: a meta-analysis.
Breast cancer research and treatment 2009 Jul .
Economopoulos KP, Sergentanis TN
| MDM2 SNP309 and cancer risk: a combined analysis.
Carcinogenesis 2007 Nov 28 (11): 2262-7.
Wilkening Stefan, Bermejo Justo Lorenzo, Hemminki Ka